JPM26: OpenEvidence makes the case for AI-powered 'medical super-intelligence'

Advances in agentic AI will enable a system of AI agents that can be sub-specialists in clinical areas, OpenEvidence co-founder Daniel Nadler said at the J.P. Morgan Healthcare Conference.